These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12029991)

  • 21. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
    Camenga D; Gill JM
    Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
    Waters DD; Brotons C; Chiang CW; Ferrières J; Foody J; Jukema JW; Santos RD; Verdejo J; Messig M; McPherson R; Seung KB; Tarasenko L;
    Circulation; 2009 Jul; 120(1):28-34. PubMed ID: 19546386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
    Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The patient at risk: who should we be treating?
    Shviro I; Leitersdorf E
    Br J Clin Pract Suppl; 1996 Jan; 77A():24-7. PubMed ID: 8729587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of medical guidelines for the prescription of statins].
    Chevalier C; Giral P; Chinaud F; Carzon M; Gartenlaub D; Blanchon B; Trutt B
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):463-73. PubMed ID: 12471339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
    Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guideline for hyperlipidemia].
    Seishima M
    Rinsho Byori; 2003 Jun; 51(6):576-80. PubMed ID: 12884746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of clinical epidemiology and intervention trial of hyperlipidemia in Japan].
    Itakura H
    Nihon Rinsho; 2002 May; 60(5):889-98. PubMed ID: 12029990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
    Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
    Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Japanese new guideline for the management of hypertension--background of its preparation and characteristics of the new guideline].
    Saruta T
    Nihon Rinsho; 2001 May; 59(5):837-40. PubMed ID: 11391979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.
    Leibovitz E; Harats D; Gavish D
    Isr Med Assoc J; 2002 Jun; 4(6):407-10. PubMed ID: 12073409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The patient at risk: who should we be treating?
    Leitersdorf E
    Br J Clin Pract Suppl; 1994 Dec; (77):24-7. PubMed ID: 19496269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Revised version of Guideline for the Management of Hyperuricemia and Gout].
    Yamanaka H
    Nihon Rinsho; 2008 Apr; 66(4):643-6. PubMed ID: 18409508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
    Hata Y; Mabuchi H; Saito Y; Itakura H; Egusa G; Ito H; Teramoto T; Tsushima M; Tada N; Oikawa S; Yamada N; Yamashita S; Sakuma N; Sasaki J;
    J Atheroscler Thromb; 2002; 9(1):1-27. PubMed ID: 12238634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.